ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Clinical phase II and III studies of an AS03‐adjuvanted H5N1 influenza vaccine produced in an EB66 ® cell culture platform
Influenza and Other Respiratory Viruses
◽
10.1111/irv.12755
◽
2020
◽
Vol 14
(5)
◽
pp. 551-563
Author(s):
Masafumi Endo
◽
Mitsuyoshi Tanishima
◽
Kayo Ibaragi
◽
Kenshi Hayashida
◽
Tadashi Fukuda
◽
...
Keyword(s):
Cell Culture
◽
Influenza Vaccine
◽
Phase Ii
◽
Clinical Phase
◽
H5n1 Influenza
◽
Phase Ii And Iii
Download Full-text
Related Documents
Cited By
References
A phase II, open-label, multicentre study to evaluate the immunogenicity and safety of an adjuvanted prepandemic (H5N1) influenza vaccine in healthy Japanese adults
BMC Infectious Diseases
◽
10.1186/1471-2334-10-338
◽
2010
◽
Vol 10
(1)
◽
Cited By ~ 10
Author(s):
Hideaki Nagai
◽
Hideyuki Ikematsu
◽
Kazuyoshi Tenjinbaru
◽
Atsushi Maeda
◽
Mamadou Dramé
◽
...
Keyword(s):
Influenza Vaccine
◽
Multicentre Study
◽
Phase Ii
◽
Open Label
◽
H5n1 Influenza
◽
Japanese Adults
Download Full-text
Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial
Vaccine
◽
10.1016/j.vaccine.2009.10.019
◽
2010
◽
Vol 28
(3)
◽
pp. 840-848
◽
Cited By ~ 56
Author(s):
Wendy Keitel
◽
Nicola Groth
◽
Maria Lattanzi
◽
Michaela Praus
◽
Anne Katrin Hilbert
◽
...
Keyword(s):
Clinical Trial
◽
Cell Culture
◽
Influenza Vaccine
◽
Phase 1
◽
Vaccine Safety
◽
H5n1 Influenza
◽
A Cell
◽
Dose Ranging
Download Full-text
Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: Homologous or heterologous booster response following two dose or single dose priming
Vaccine
◽
10.1016/j.vaccine.2012.07.077
◽
2012
◽
Vol 30
(43)
◽
pp. 6127-6135
◽
Cited By ~ 21
Author(s):
Maikel V.W. van der Velden
◽
Gerald Aichinger
◽
Eva Maria Pöllabauer
◽
Alexandra Löw-Baselli
◽
Sandor Fritsch
◽
...
Keyword(s):
Cell Culture
◽
Immune Response
◽
Single Dose
◽
Influenza Vaccine
◽
Vero Cell
◽
H5n1 Influenza
◽
Memory Immune Response
Download Full-text
Peripheral and penile angiography with iotrolan 280 versus non-ionic monomers: results of the European clinical phase II and III trials
European Radiology
◽
10.1007/bf02343258
◽
1995
◽
Vol 5
(S2)
◽
pp. S30-S38
◽
Cited By ~ 2
Author(s):
J. K. Gmeinwieser
◽
B. -I. Wenzel-Hora
Keyword(s):
Phase Ii
◽
Clinical Phase
◽
Phase Ii And Iii
Download Full-text
Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: A sequential Phase I and Phase II clinical trial
Vaccine
◽
10.1016/j.vaccine.2008.11.003
◽
2009
◽
Vol 27
(5)
◽
pp. 786-791
◽
Cited By ~ 35
Author(s):
N. Groth
◽
E. Montomoli
◽
C. Gentile
◽
I. Manini
◽
R. Bugarini
◽
...
Keyword(s):
Clinical Trial
◽
Cell Culture
◽
Influenza Vaccine
◽
Phase I
◽
Mammalian Cell
◽
Phase Ii
◽
Mammalian Cell Culture
◽
Phase Ii Clinical Trial
◽
Sequential Phase
Download Full-text
Human medicines European public assessment report (EPAR): Vepacel, Prepandemic influenza vaccine (H5N1) (whole virion, inactivated,prepared in cell culture), Influenza, Human,Immunization,Disease Outbreaks, Date of authorisation: 17/02/2012, Revision: 9, Status: Authorised
Case Medical Research
◽
10.31525/cmr-962c3e
◽
2019
◽
Author(s):
Keyword(s):
Cell Culture
◽
Influenza Vaccine
◽
Disease Outbreaks
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Safety, Tolerability and Immunogenicity of an Trivalent Inactivated Cell-Culture Influenza Vaccine in Healthy Adults
Case Medical Research
◽
10.31525/ct1-nct03893669
◽
2019
◽
Author(s):
Keyword(s):
Cell Culture
◽
Influenza Vaccine
◽
Healthy Adults
Download Full-text
Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6 months through <18 years of age: A randomized controlled phase II dose-finding trial
Vaccine
◽
10.1016/j.vaccine.2021.02.014
◽
2021
◽
Author(s):
Lee-Jah Chang
◽
Evan J. Anderson
◽
Robert Jeanfreau
◽
Ying He
◽
Bryony Hicks
◽
...
Keyword(s):
Influenza Vaccine
◽
Phase Ii
◽
Dose Finding
◽
Randomized Controlled
◽
High Doses
◽
Quadrivalent Influenza Vaccine
Download Full-text
A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease
Ophthalmology
◽
10.1016/j.ophtha.2019.01.024
◽
2019
◽
Vol 126
(6)
◽
pp. 792-800
◽
Cited By ~ 7
Author(s):
David L. Wirta
◽
Gail L. Torkildsen
◽
Helen R. Moreira
◽
John D. Lonsdale
◽
Joseph B. Ciolino
◽
...
Keyword(s):
Phase Ii
◽
Dry Eye
◽
Phase Ii Study
◽
Dry Eye Disease
◽
Eye Disease
◽
Clinical Phase
Download Full-text
Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials
Supportive Care in Cancer
◽
10.1007/s00520-012-1384-0
◽
2012
◽
Vol 20
(11)
◽
pp. 2661-2668
◽
Cited By ~ 19
Author(s):
Linda T. Vahdat
◽
Eva S. Thomas
◽
Henri H. Roché
◽
Gabriel N. Hortobagyi
◽
Joseph A. Sparano
◽
...
Keyword(s):
Clinical Trials
◽
Peripheral Neuropathy
◽
Phase Ii
◽
Phase Ii And Iii
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close